Andere Kunden interessierten sich auch für
![Micronized carvedilol SR matrix tablet for imporved dissolution]( "Micronized carvedilol SR matrix tablet for imporved dissolution")
Micronized carvedilol SR matrix tablet for imporved dissolution23,99 €![Development and optimization of press coated tablet of Carvedilol]( "Development and optimization of press coated tablet of Carvedilol")
Development and optimization of press coated tablet of Carvedilol38,99 €![Development of Carvedilol Phosphate sustained release tablet]( "Development of Carvedilol Phosphate sustained release tablet")
Development of Carvedilol Phosphate sustained release tablet38,99 €![Fabrication of SR Matrix Tablet for Arthritis Treatment]( "Fabrication of SR Matrix Tablet for Arthritis Treatment")
Fabrication of SR Matrix Tablet for Arthritis Treatment32,99 €![Formulation Development & Optimization of Valsartan SR Matrix Tablet]( "Formulation Development & Optimization of Valsartan SR Matrix Tablet")
Formulation Development & Optimization of Valsartan SR Matrix Tablet41,99 €![Ambroxol HCl SR Tablet]( "Ambroxol HCl SR Tablet")
Ambroxol HCl SR Tablet38,99 €![Formulation and Evaluation of Carvedilol Pulsincap System]( "Formulation and Evaluation of Carvedilol Pulsincap System")
Formulation and Evaluation of Carvedilol Pulsincap System51,99 €
Matrix tablets containing carvedilol phosphate were prepared using 27 formulations in three batch series where different ratios of K4M CR and K15M CR were used as release retarding agents. Avicel PH 101, Starch 1500 and Lactose monohydrate were used as diluents in the formulation of three batches. The data were subjected to different models in order to evaluate their release kinetics and mechanisms. Tablets in case of all formulations showed more than 50% of drug release in 12 h when Methocel K4M CR and K15M CR constituted 18% and 15% of the matrix respectively. It was found that Avicel PH 101 decreases while Starch 1500 and Lactose monohydrate increases drug release.